ucsf banner
Home    :   Contact Us
Teri Liegler, PhD

Teri Liegler, PhD
Assistant Adjunct Professor II, Research Director ARI-UCSF Laboratory of Clinical Virology. Director, UCSF-GIVI CFAR Virology Core Laboratory

Research Interests
Translational research in HIV/AIDS and associated diseases, molecular diagnostic assay development, viral transmission, antiretroviral drug resistance, viral reservoirs and vaccine development

Select Publications

1) K. Bourara, T.J. Liegler and R.M. Grant. Target Cell APOBEC3C can induce limited G-to-A mutation in HIV-1. PloS Pathogens 2007, 3:1477-1485.
2) S.G. Deeks, J. Lu, R. Hoh, T.B. Nielands, G. Beatty, W. Huang, T. Liegler, P. Hunt, J.N. Martin, and D.R. Kuritzkes. Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen (with commentary). JID 2007;195:387-391.
3) S.S. Spudich, N. Lollo, T. Liegler, S.G. Deeks and R.W. Price. Cerebrospinal fluid HIV treatment benefit in the setting of systemic virological suppression and failure (with commentary). JID 2006;194:1686-1696.
4) T.J. Liegler and R.M. Grant. Nucleic acid based HIV-1 viral load assays. In HIV InSite Knowledge Base [textbook on-line] 2006; (http://hivinsite.ucsf.edu/InSite?page=kb-02-02-02-01).
5) R.M. Grant, F.M. Hecht, M. Warmerdam, L. Liu, T. Liegler, C.J. Petropoulos, N.S. Hellman, M. Chesney, M.P. Busch and J.O. Kahn. Time trends in primary HIV-1 drug resistance among persons recently infected in San Francisco. JAMA 2002; 282:181-188.

View PubMed results for Teri Liegler, PhD

Education & Training

BS, University of California, Irvine, CA, 1980

PhD, University of California, Irvine, CA, 1986